Keywords: fda, committee, gives, nod, biogen, amevive, psoriasis

FDA committee gives nod to Biogen's Amevive for psoriasis

Article | 03 June 2002

• Print This

Despite the uncertainty about its long-term effects, the US Food andDrug Administration's Dermatologic and Ophthalmic Drugs Advisory Committee voted eight-to-two ...

Enjoying this article? To continue reading you need to login or subscribe.